|
Company:
|
AXOGEN, INC. (AXGN)
|
|
Form Type:
|
8-K
|
|
Filing Date:
|
7/11/2013
|
|
CIK:
|
0000805928
|
|
Address:
|
13859 PROGRESS BLVD
SUITE 100
|
|
City, State, Zip:
|
ALACHUA, Florida 32615
|
|
Telephone:
|
(386) 462-6817
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$3.19
|
Change:
0.01 (0.31%)
|
Trade Time:
Mar 03
|
Market Cap:
$77.25M
|
|
|
|
|
|
|
Description of Business
|
|
We are a leading medical technology company dedicated to advancing the science
and commercialization of peripheral nerve repair solutions. Peripheral nerves
provide the pathways for both motor and sensory signals throughout the body and
their damage can result in the loss of muscle function and/or feeling.
Nerves can be damaged in a number of ways. When a nerve is cut due to a
traumatic injury or surgery, functionality of the nerve may be compromised,
causing the nerve to no longer carry the signals to and from the brain to the
muscles and skin. This type of injury generally requires a surgical repair. The
traditional gold standard has been to either suture the nerve ends together
directly without tension or to bridge the gap between the nerve ends with a less
important nerve surgically removed from elsewhere in the patient's own body
referred to as nerve autograft.
|
|
|
|